In taking their next step in aggressively increasing sales and growing market adoption, Innovative Trauma Care (iTraumaCare™) announced Joseph P. Brennan as the new President and Chief Executive Officer on Oct 22, 2014. Click here for more details.
iTraumaCare™ is an early stage medical device company focused on developing and marketing solutions to address the common causes of preventable death in traumatic injury scenarios. Founded and incorporated in Edmonton, Canada in 2010, with US headquarters in San Antonio, Texas, iTraumaCare's premier product is the iTClamp™ Hemorrhage Control System, which addresses the number one cause of preventable death in trauma scenarios – massive hemorrhage.
The iTClamp™ Hemorrhage Control System, iTraumaCare's first product, is a temporary wound closure device to control severe bleeding within seconds of application to a penetrating injury. The iTClamp seals the edges of a wound closed to create a temporary pool of blood under pressure, which forms a stable clot that mitigates further blood loss until the wound can be surgically repaired. No comparable product exists in the point-of-injury space, solving an unmet medical need.
Other iTraumaCare News
October 15, 2014- iTraumaCare® Receives Expanded Indication from FDA for iTClamp® Hemorrhage Control System.
September 24, 2014- iTraumaCare® Closes One Hundred Accounts in North America.